Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort

Status Recruiting

Clinical Trial Summary

The cohort is intended to study the phenotypic expressions of the pseudoxanthoma elasticum (PXE) disease in various tissues (eye, skin, arteries, etc).

Clinical Trial Description

This national french cohort is intended to improve our knowledge on the PXE disease. The study of phenotypic expression of the diseases is focused on cutaneous, opthalmologic and vascular tissues. All investigations are included in a yearly follow-up for these patients and collected in a database.

Plasma are also collected for all patients and stored in our clinical research biological center in Angers, including genetic (DNA) material extracted from diagnostic skin biopsy. French Ministry of Teaching and Research Authorisation number for the PXE collection is AC 2008 871. Declarative number is DC 2008 870. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Pseudoxanthoma Elasticum

Clinical Trial Details

NCT number	NCT01446380
Study type	Observational
Source	University Hospital, Angers
Contact	Ludovic MARTIN, MD PhD
Phone	33(2)41-35-34-19
Email	LuMartin@chu-angers.fr
Status	Recruiting
Phase	N/A
Start date	June 2008
Completion date	January 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02537054` - Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)	Phase 2
Completed	`NCT05569252` - A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum	Phase 2
Recruiting	`NCT05662085` - Progression Rate of Pseudoxanthoma Elasticum-associated Choroidal and Retinal Degeneration
Completed	`NCT03070860` - What's Happen Under the Calcification Process in Pseudoxanthoma Elasticum	N/A
Completed	`NCT01446393` - Functional and Structural Characterization of Arteriopathy in Pseudoxanthoma Elasticum (PXE)	N/A
Completed	`NCT00470977` - Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy	Phase 1/Phase 2
Recruiting	`NCT03758534` - Natural History of GACI With or Without ARHR2 or PXE
Recruiting	`NCT05734196` - The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency	Phase 1
Not yet recruiting	`NCT06462547` - ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency	Phase 2
Recruiting	`NCT03813550` - Intestinal Microbiota and Vitamin K Levels in PXE Patients (IMPROVE Study)	N/A
Not yet recruiting	`NCT03364504` - Biological Collection of Kidney Cells	N/A
Active, not recruiting	`NCT02108392` - Characterization of Pseudoxanthoma Elasticum
Recruiting	`NCT01731080` - Arterial Wall Calcium Load in Pseudoxanthoma Elasticum	N/A
Completed	`NCT00555113` - Evolution of Visual Impairment During Pseudoxanthoma Elasticum	N/A
Completed	`NCT00341419` - Genetic Analysis of Patients With Pseudoxanthoma Elasticum
Withdrawn	`NCT04441671` - Oral Pyrophosphate Absorption in PXE Disease	Phase 2
Recruiting	`NCT04868578` - PPI Supplementation to Fight ECtopIc Calcification in PXE	N/A
Completed	`NCT05025722` - Pseudoxanthoma Elasticum (PXE) Natural History Biomarkers in PXE Individuals and Their Biological Non-PXE Siblings
Completed	`NCT01525875` - Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)	Phase 2
Completed	`NCT05246189` - Employment of Patients With Pseudoxanthoma Elasticum